Cargando…

Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma

AIM: To investigate if pre-treatment platelet counts could provide prognostic information in patients with rectal adenocarcinoma that received neo-adjuvant treatment. METHODS: Platelet number on diagnosis of stage II and III rectal cancer was evaluated in 51 patients receiving neo-adjuvant treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steele, Morgan, Voutsadakis, Ioannis A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241527/ https://www.ncbi.nlm.nih.gov/pubmed/28144399 http://dx.doi.org/10.4251/wjgo.v9.i1.42

Ejemplares similares

Construction of a clinical survival prognostic model for middle-aged and elderly patients with stage III rectal adenocarcinoma
por: Liu, Hao, et al.
Publicado: (2021)

Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022)

Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy
por: Zhao, Jie-Yi, et al.
Publicado: (2022)

Prognostic significance of primary tumor localization in stage II and III colon cancer
por: Sakin, Abdullah, et al.
Publicado: (2018)

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2017)

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
por: Suenaga, Yasuhito, et al.
Publicado: (2019)

Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies
por: Voutsadakis, Ioannis A
Publicado: (2020)

Significance of platelet count in children admitted with bronchiolitis
por: Al Shibli, Amar, et al.
Publicado: (2017)

Ratio of mean platelet volume to platelet count is a potential surrogate marker predicting liver cirrhosis
por: Iida, Hiroya, et al.
Publicado: (2018)

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
por: Reggiani Bonetti, Luca, et al.
Publicado: (2017)

Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients
por: Lin, Jian-Xian, et al.
Publicado: (2019)

Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer
por: Kong, Xiang-Quan, et al.
Publicado: (2018)

Low platelet count: Predictor of death and graft loss after liver transplantation
por: Beltrame, Pedro, et al.
Publicado: (2019)

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study
por: Scheer, René, et al.
Publicado: (2017)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
por: Li, Yi-Fan, et al.
Publicado: (2023)

Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
por: Cho, Jang Ho, et al.
Publicado: (2017)

Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas
por: Lin, Hua-Peng, et al.
Publicado: (2018)

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps
por: Yin, Jian-Dong, et al.
Publicado: (2020)

Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection
por: Kang, Wen-Zhe, et al.
Publicado: (2022)

Optimal postoperative surveillance strategies for stage III colorectal cancer
por: Park, Min Young, et al.
Publicado: (2021)

Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
por: Digklia, Antonia, et al.
Publicado: (2014)

Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
por: Surana, Pallavi, et al.
Publicado: (2021)

Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8(th) Edition) staging system for pancreatic cancer
por: Yu, Hai-Feng, et al.
Publicado: (2018)

Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer
por: Cheong, Chinock, et al.
Publicado: (2020)

Radiomics for predicting perineural invasion status in rectal cancer
por: Li, Mou, et al.
Publicado: (2021)

Radiomics of rectal cancer for predicting distant metastasis and overall survival
por: Li, Mou, et al.
Publicado: (2020)

Role of pre-existing incomplete intestinal metaplasia in gastric adenocarcinoma: A retrospective case series analysis
por: Bogdanova, Inga, et al.
Publicado: (2023)

Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer
por: Ren, Dong-Lin, et al.
Publicado: (2019)

Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations
por: Muñoz-Guglielmetti, Diego, et al.
Publicado: (2021)

Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer
por: Tomás, Tiago Cruz, et al.
Publicado: (2022)

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019)

Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up
por: Hosoda, Kei, et al.
Publicado: (2017)

Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours
por: Thomaschewski, Michael, et al.
Publicado: (2018)

No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer
por: Wu, Yun-Zi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c09m300mho5a0jpusipupnhdvh